123 related articles for article (PubMed ID: 23958207)
21. RASSF1A: Not a prototypical Ras effector.
Gordon M; Baksh S
Small GTPases; 2011 May; 2(3):148-157. PubMed ID: 21776416
[TBL] [Abstract][Full Text] [Related]
22. Structural and thermodynamic characterization of Nore1-SARAH: a small, helical module important in signal transduction networks.
Makbul C; Constantinescu Aruxandei D; Hofmann E; Schwarz D; Wolf E; Herrmann C
Biochemistry; 2013 Feb; 52(6):1045-54. PubMed ID: 23331050
[TBL] [Abstract][Full Text] [Related]
23. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; Wong AY; Huang DP
Oncol Rep; 2004 Oct; 12(4):781-7. PubMed ID: 15375500
[TBL] [Abstract][Full Text] [Related]
24. Promoter methylation status of Ras-association domain family members in pheochromocytoma.
Richter AM; Zimmermann T; Haag T; Walesch SK; Dammann RH
Front Endocrinol (Lausanne); 2015; 6():21. PubMed ID: 25750636
[TBL] [Abstract][Full Text] [Related]
25. Rassf Proteins as Modulators of Mst1 Kinase Activity.
Bitra A; Sistla S; Mariam J; Malvi H; Anand R
Sci Rep; 2017 Mar; 7():45020. PubMed ID: 28327630
[TBL] [Abstract][Full Text] [Related]
26. RASSF10 is epigenetically silenced and functions as a tumor suppressor in gastric cancer.
Wei Z; Chen X; Chen J; Wang W; Xu X; Cai Q
Biochem Biophys Res Commun; 2013 Mar; 432(4):632-7. PubMed ID: 23428420
[TBL] [Abstract][Full Text] [Related]
27. RASSF effectors couple diverse RAS subfamily GTPases to the Hippo pathway.
Dhanaraman T; Singh S; Killoran RC; Singh A; Xu X; Shifman JM; Smith MJ
Sci Signal; 2020 Oct; 13(653):. PubMed ID: 33051258
[TBL] [Abstract][Full Text] [Related]
28. The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways.
Lock FE; Underhill-Day N; Dunwell T; Matallanas D; Cooper W; Hesson L; Recino A; Ward A; Pavlova T; Zabarovsky E; Grant MM; Maher ER; Chalmers AD; Kolch W; Latif F
Oncogene; 2010 Jul; 29(30):4307-16. PubMed ID: 20514026
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners.
Rezaei Adariani S; Kazemein Jasemi NS; Bazgir F; Wittich C; Amin E; Seidel CAM; Dvorsky R; Ahmadian MR
J Biol Chem; 2021; 296():100626. PubMed ID: 33930461
[TBL] [Abstract][Full Text] [Related]
30. The RASSF1A tumor suppressor.
Donninger H; Vos MD; Clark GJ
J Cell Sci; 2007 Sep; 120(Pt 18):3163-72. PubMed ID: 17878233
[TBL] [Abstract][Full Text] [Related]
31. Regulation of p53 by ING family members in suppression of tumor initiation and progression.
Jafarnejad SM; Li G
Cancer Metastasis Rev; 2012 Jun; 31(1-2):55-73. PubMed ID: 22095030
[TBL] [Abstract][Full Text] [Related]
32. Ras signaling through RASSF proteins.
Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
[TBL] [Abstract][Full Text] [Related]
33. Unravelling the tumor-suppressive functions of FOXO proteins.
Dansen TB; Burgering BM
Trends Cell Biol; 2008 Sep; 18(9):421-9. PubMed ID: 18715783
[TBL] [Abstract][Full Text] [Related]
34. The Tumor Suppressor Role of the Ras Association Domain Family 10.
Hou Y; Li S; Du W; Li H; Wen R
Anticancer Agents Med Chem; 2020; 20(18):2207-2215. PubMed ID: 32664845
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic down regulation of RASSF10 and its possible clinical implication in prostate carcinoma.
Dansranjavin T; Wagenlehner F; Gattenloehner S; Steger K; Weidner W; Dammann R; Schagdarsurengin U
Prostate; 2012 Oct; 72(14):1550-8. PubMed ID: 22415519
[TBL] [Abstract][Full Text] [Related]
36. The Cross-Talk Between the TNF-α and RASSF-Hippo Signalling Pathways.
Oceandy D; Amanda B; Ashari FY; Faizah Z; Azis MA; Stafford N
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083564
[TBL] [Abstract][Full Text] [Related]
37. MST2-RASSF protein-protein interactions through SARAH domains.
Sánchez-Sanz G; Matallanas D; Nguyen LK; Kholodenko BN; Rosta E; Kolch W; Buchete NV
Brief Bioinform; 2016 Jul; 17(4):593-602. PubMed ID: 26443615
[TBL] [Abstract][Full Text] [Related]
38. RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer.
Richter AM; Küster MM; Woods ML; Walesch SK; Gökyildirim MY; Krueger M; Dammann RH
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817988
[TBL] [Abstract][Full Text] [Related]
39. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
40. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
